Conversely, TNFα blockade has been demonstrated to uncouple the efficacy and toxicity of ICIs targeting PD-1 in the treatment of ICI-related colitis in animal models (Esfahani et al., 2020a). This evidence concerns the gene PDCD1 and colitis.